Neurocrine Bioscience buy Royal Bank of Canada
Start price
29.10.25
/
50%
€117.85
Target price
29.10.26
€137.36
Performance (%)
13.32%
Price
05.12.25
€133.55
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 13.32%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 1.830% | 1.830% |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Royal Bank Of Canada from $156.00 to $160.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.05
05.09.25
05.09.25
€127.74
05.09.26
05.09.26
8.53%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
18.76%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
22.69%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
26.11%
05.12.25
05.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
60.17%
05.12.25
05.12.25